- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02751489
Human Phototoxicity Test
June 16, 2016 updated by: Bayer
To determine the phototoxic potential of a topically applied article in human subjects
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Piscataway, New Jersey, United States, 08854
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be male or female between the ages of 18 and 60 inclusive;
- Be lightly pigmented (Fitzpatrick Skin Type I, II, III);
- Have read and signed the written Informed Consent Form and have completed a Health Insurance Portability and Accountability (HIPAA) Authorization Form in conformance with 45CFR Parts 160 and 164;
- Be in general good health as determined by the subject's medical history and in the discretion of the investigator;
Exclusion Criteria:
- Have a visible sunburn;
- Have a history of sun hypersensitivity/photosensitivity or photosensitive dermatoses;
- Must not have a known sensitivity or allergy against any of the active and non-active ingredients of the test product.
- Have a history of allergies or sensitivities to cosmetics, toiletries or any dermatological products
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bain De Soliel - Solid
All subjects are patched with the same product
|
0.05 gm/cm2 of each test product is applied to duplicate skin sites (approximately 2 x 2 cm each) on the lower or mid-back.
After the test articles have dried for 5 to 15 min, the sites are covered by the appropriate patch.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Intensity of skin reactions is evaluated by 5 point scale
Time Frame: Up to 48 hours
|
Up to 48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2016
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
April 22, 2016
First Submitted That Met QC Criteria
April 22, 2016
First Posted (Estimate)
April 26, 2016
Study Record Updates
Last Update Posted (Estimate)
June 17, 2016
Last Update Submitted That Met QC Criteria
June 16, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18600
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sunscreening Agents
-
HALEONCompletedSunscreening AgentsUnited States
-
BayerTerminated
-
BayerCompletedSunscreening AgentsUnited States
-
HALEONCompletedSunscreening AgentsUnited States
Clinical Trials on Bain De Soliel - Solid
-
University Hospital, Basel, SwitzerlandCompleted